Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Interventional × Dysbiosis × Clear all

Phase

Status

Completed 3 Recruiting 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 33 Colorectal Neoplasms 23 Prostatic Neoplasms 21 Uterine Cervical Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Anxiety Disorders 11 Lymphoma, Follicular 10 Lung Neoplasms 9 Motor Activity 8 Brain Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 7 Urinary Bladder Neoplasms 6 Sarcoma 6 Esophageal Neoplasms 6 Depression 6 Pain 5 Ovarian Neoplasms 5 Head and Neck Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Epilepsy 5 Cholangiocarcinoma 5 Uterine Cervical Dysplasia 4 Small Cell Lung Carcinoma 4 Recurrence 4 Polycystic Ovary Syndrome 4 Pancreatic Neoplasms 4 Myelodysplastic Syndromes 4 Lymphoma, Large B-Cell, Diffuse 4

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Metronidazole 1 Lacteol 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡